Literature DB >> 11909561

Comparison of results of coronary angioplasty for acute myocardial infarction in patients > or =75 years of age versus patients <75 years of age.

Koyu Sakai1, Yoshihisa Nakagawa, Takeshi Kimura, Takahiro Doi, Hiroyoshi Yokoi, Masashi Iwabuchi, Naoya Hamasaki, Katsumi Inoue, Hideyuki Nosaka, Masakiyo Nobuyoshi.   

Abstract

We reviewed 1,063 consecutive patients treated with direct coronary angioplasty for acute myocardial infarction (AMI): 261 were > or =75 and 802 were <75 years of age. Compared with the younger group, the older group had a higher percentage of women (48% vs 22%, p <0.0001), multivessel coronary disease (50% vs 39%, p <0.01), overall in-hospital mortality (8.4% vs 3.7%, p <0.01), cardiac mortality rate (6.1% vs 3.1%, p <0.05), and noncardiac mortality rate (2.3% vs 0.6%, p <0.05). Successful reperfusion was achieved in both groups at a similarly high rate (93% and 95%, p = NS). Hospital mortality was similar whether reperfusion was successful or failed. Successful compared with unsuccessful angioplasty decreased mortality rates in the older (6.6% vs 33%, p <0.0001) and younger (3.0% vs 18%, p <0.0001) groups. When reperfusion was successful, the cardiac mortality rate in older patients was not significantly higher than in younger patients: 4.1% vs 2.4%, p = NS.

Entities:  

Mesh:

Year:  2002        PMID: 11909561     DOI: 10.1016/s0002-9149(02)02187-2

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  2 in total

1.  Outcomes of contemporary interventional therapy of ST elevation infarction in patients older than 75 years.

Authors:  Stefan Zimmermann; Susanne Ruthrof; Kathrin Nowak; Lutz Klinghammer; Josef Ludwig; Werner G Daniel; Frank A Flachskampf
Journal:  Clin Cardiol       Date:  2009-02       Impact factor: 2.882

2.  A Study of Prognosis, Outcome, and Changing Tendency of Hospitalized AMI Patients in Beijing Third-Grade A-Level Traditional Chinese Medicine Hospitals from 1999 to 2008.

Authors:  Ju-Ju Shang; Hui Shi; Qi Zhou; Wei Gao; Hong-Xu Liu
Journal:  Evid Based Complement Alternat Med       Date:  2012-03-22       Impact factor: 2.629

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.